The Relatıonship of Mean Platelet Volume Levels With MEFV and HLA-B27 Gene Analysis

2016 ◽  
2016 ◽  
Vol 46 ◽  
pp. 251-258 ◽  
Author(s):  
Seyit Murat BAYRAM ◽  
Gül GÜRSOY ◽  
Aslı ARAZ GÜNGÖR ◽  
Fatih GÜNGÖR ◽  
Eray ATALAY

2014 ◽  
Vol 20 (2) ◽  
pp. 182 ◽  
Author(s):  
Ahmet Tutoglu ◽  
Ahmet Boyaci ◽  
Ozcan Kocaturk ◽  
Suna Sarikaya ◽  
Mahmut Kul ◽  
...  

Open Medicine ◽  
2018 ◽  
Vol 13 (1) ◽  
pp. 450-455
Author(s):  
Halil Taskaynatan ◽  
Ahmet Alacacioglu ◽  
Yuksel Kucukzeybek ◽  
Umut Varol ◽  
Yasar Yildiz ◽  
...  

AbstractBackgroundMean platelet volume (MPV) is a parameter that increases during thrombotic and cardiovascular events. Tamoxifen (Tmx) and aromatase inhibitors (AIs), which are adjuvant endocrine therapies, may cause serious side effects, such as vascular thrombosis. The present study investigated the changes in MPV values of breast cancer patients receiving long-term adjuvant hormone therapy and the relationship of MPV with adverse effects of hormonotherapy.MethodsData of 261 patients who had pathologically confirmed estrogen or progesterone receptor positive invasive breast cancer and had received hormonotherapy for at least a 5-year period were retrospectively analyzed. MPV levels were measured at baseline and at the first and fifth year of hormone therapy.ResultsAll patients were females and their median age was 50 years (range, 27–78 years). The mean MPV value was significantly increased in all patients in the Tmx, AI, and switch groups over time (p<0.001).ConclusionThis is the first study evaluating the relationship between the 5-year adjuvant endocrine therapy and changes in MPV values in breast cancer patients. Monitoring changes in MPV values may be predictive for severe side effects in breast cancer patients receiving hormone therapy.


2016 ◽  
Vol 46 ◽  
pp. 1292-1299 ◽  
Author(s):  
Aslı Araz GÜNGÖR ◽  
Gül GÜRSOY ◽  
Fatih GÜNGÖR ◽  
Seyit Murat BAYRAM ◽  
Eray ATALAY

2018 ◽  
Vol 38 (3) ◽  
Author(s):  
Juxiang Liu ◽  
Xingguang Liu ◽  
Youpeng Li ◽  
Jinxing Quan ◽  
Suhong Wei ◽  
...  

The aim of the present study was to investigate the correlation of neutrophil to lymphocyte ratio (NLR), mean platelet volume (MPV), and platelet distribution width (PDW) with diabetic nephropathy (DN) and diabetic retinopathy (DR). We searched for eligible studies from PubMed, Embase, Web of Science, and CNKI up to 1 December 2017. Standardized mean difference (SMD) was calculated with a confidence interval (CI) of 95%. A total of 48 studies were included in our meta-analysis. Compared with patients with type Ⅱ diabetes mellitus (T2DM) and without DR, NLR, MPV, and PDW were higher in patients with DR (SMD = 0.77; 95% CI: 0.49–1.05; P<0.001; SMD = 0.68; 95% CI: 0.36–0.99; P<0.001; SMD = 0.52; 95% CI: 0.28–0.76; P<0.01). Compared with patients with T2DM and without DN, NLR, MPV, and PDW were higher in patients with DN (SMD = 0.63; 95% CI: 0.43–0.83; P<0.001; SMD = 0.81; 95% CI: 0.36–1.25; P<0.001; SMD = 0.70; 95% CI: 0.50–0.90; P<0.001). We also found that MPV was strongly associated with the severity of DR, and NLR was closely related to the degree of DN. Our findings indicated that NLR, MPV, and PDW could be recommended as inexpensive diagnostic biomarkers for DN and DR. However, considering several limitations in the present study, further high-quality clinical studies should be performed to investigate the relationship of NLR, MPV, and PDW to DN and DR.


Sign in / Sign up

Export Citation Format

Share Document